← Back to Vaccine Database

RBD (baculovirus production expressed in Sf9 cells) Recombinant SARS-CoV-2 vaccine (Sf9 Cell)

Protein based vaccine · VDDBV0627

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials6

NCT IDPhaseDisease / Condition
NCT04530656 Phase 1COVID-19
NCT05013983 Phase 2COVID-19
NCT04640402 Phase 2COVID-19
NCT04718467 Phase 2COVID-19
NCT04887207 Phase 3COVID-19
NCT04904471 Phase 3COVID-19